换一批
换一批Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancer.
第一作者：
Ronald C,Chen
第一单位：
Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7295, USA.
作者：
主题词
老年人(Aged);雄激素拮抗药(Androgen Antagonists);抗肿瘤药(Antineoplastic Agents);无病生存(Disease-Free Survival);剂量效应关系, 药物(Dose-Response Relationship, Drug);随访研究(Follow-Up Studies);促性腺素释放激素(Gonadotropin-Releasing Hormone);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);前瞻性研究(Prospective Studies);前列腺特异抗原(Prostate-Specific Antigen);前列腺肿瘤(Prostatic Neoplasms);辐射增敏药(Radiation-Sensitizing Agents);放射治疗剂量(Radiotherapy Dosage);放射疗法, 调强适形(Radiotherapy, Intensity-Modulated);紫杉烷类(Taxoids);治疗结果(Treatment Outcome)
DOI
10.1111/j.1464-410X.2012.11536.x
PMID
23016517
发布时间
2019-05-01
- 浏览35
BJU international
E721-6页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
